Valiant's Subsidiary Jiumu Chemical Clears Beijing Stock Exchange Listing Review

Stock News
Yesterday

Valiant Co.,Ltd. (002643.SZ) has announced a significant milestone for its controlling subsidiary, Yantai Jiumu Chemical Co., Ltd., which has successfully passed the listing review for the Beijing Stock Exchange. The company, also known as Jiumu Chemical, is currently listed on the National Equities Exchange and Quotations system under the securities code 874382 and has been pursuing a public offering to unspecified qualified investors with the aim of listing on the BSE.

Jiumu Chemical submitted its application materials for the public offering and BSE listing to the Beijing Stock Exchange on September 11, 2025, and received the official acceptance notice with the reference number GF2025090003 on September 18, 2025. A year later, on September 16, 2026, the BSE released the outcome of the 85th review meeting of its Listing Committee, confirming that Yantai Jiumu Chemical meets all requirements concerning issuance conditions, listing standards, and information disclosure obligations.

The approval marks a key step forward in the subsidiary's path toward a BSE debut, which could enhance its capital-raising capabilities and support its long-term growth strategy. For Valiant, this development underscores its commitment to expanding its presence in the specialty chemical sector through its core holdings.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10